Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58 , 213".

Published in: Medicina (Kaunas, Lithuania) (2022)

We appreciate Ahmed Sami Aljabali and his colleagues for their interest and comments [...].

Keyphrases